Kronos Bio's total assets for Q4 2024 were $124.36M, a decrease of -17.10% from the previous quarter. KRON total liabilities were $36.78M for the fiscal quarter, a -5.43% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.